Royalty Report: Medical, Ophthalmological, Supply – Collection: 1513

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 13

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 13

Primary Industries

  • Medical
  • Ophthalmological
  • Supply
  • Device
  • Eye Surgery Procedure
  • Personal Care Products
  • Diagnostic
  • Surgical

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 1513

License Grant
The Company hereby grants a world-wide, nonexclusive, nontransferable, royalty-bearing license to use the Licensed Patents to manufacture, have manufactured, sell, distribute and market the Licensed Products (soft intraocular lens products) and to practice the inventions covered by the Licensed Patents.
License Property
Licensed Products shall mean any intraocular lens products, and devices used to insert and/or apply the intraocular lens products, made, used or sold for use in a manner which is covered by a Valid Patent Claim of the Licensed Patents. Patent No. 4,573,998 Methods for Implantation of Deformable Intraocular Lenses; Patent No. 4,715,373 Devices for implantation of Deformable Intraocular Lens Structures; Patent No. 4,702,244 Surgical Device for Implantation of a Deformable Intraocular Lens.
Field of Use
The rights granted apply to implantation of lenses.

IPSCIO Record ID: 1890

License Grant
The Licensor granted to the License  a world-wide, nonexclusive, non-transferable, royalty-bearing license to use the Licensed Patents to manufacture, have manufactured, sell, distribute and market the Licensed Products and to practice the inventions covered by the Licensed Patents.

Licensed Products shall mean any product, including intraocular lenses, especially made, used, or sold by Mentor to its customers, for use in a manner covered by a Valid Patent Claim of the 998 Patent.

License Property
The 998 patent shall mean U.S. Patent No. 4,573,998 entitled Methods for implantation of Deformable Intraocular.
Field of Use
The rights granted apply to the healthcare industry relating to the eye.

IPSCIO Record ID: 159683

License Grant
Licensor hereby grants to Licensee and its Affiliates, upon the terms and conditions herein specified, a worldwide non-exclusive license under the Licensed Technology and the Licensed Patent. There is no right to sublicense included in this grant.
License Property
Licensed Patent shall mean United States Patent No. 4,573,998 and any corresponding foreign patent applications or patents issued March 4, 1986, and entitled Methods for Implantation of Deformable Intraocular Lenses and any reissue thereof.
Field of Use
This agreement pertains to the medical industry in relation to intraocular lens structures.

IPSCIO Record ID: 1514

License Grant
The license was granted for use on the exclusive territory to the Swiss Licensee by the Russian Licensor.
License Property
Licenser possesses the 'Technology for Producing Collagen-Based Cross-Linked Drain', and the Licensiate wants to acquired the license on this technology. Technology of production intraocular lenses from collagen co-polimers.   Artificial eye lenses, which are implantated through small sizes, are most perspective.  Several requirements are produced to artificial eye lenses like elasticity, biocompatibility, low specific density and high solidity on rupture.  Artificial eye lenses from collagen co-polimers corresponds to these principles.

Technology of production intraocular lenses from collagen co-polimers Nowadays, intraocular correction is one of the basic medical treatment method of vision body disease.
Artificial eye linses are used not only when cataract, but also for removal of refraction anomalies.
Artificial eye lenses, which are implantated through small sizes, are most perspective. Several requirements are produced to artificial eye lenses like elasticity, biocompatibility, low specific density and high solidity on rupture. Artificial eye lenses from collagen co-polimers corresponds to these principles.
Highest elasticity, hight solidity on rupture are the main quality of these products. It allows to make implantation as tool-making method of injection also.
Lenses, which are maked an special technology, passed experimental and hospital tests successfully and inculcated in wide surgical practice as in Eye Microsurgery Intersectoral Research and Technology Complex so in the other Russian and CIS hospitals.

US patent N 6.286.829 (Russion application N 4745668) 'Biocompatible polymer material and a process for producing same'
USA patent N 5258025 (Russian application N 4881670) 'correctional intraocular lens'

IPSCIO Record ID: 2601

License Grant
Licensor hereby grants under United States Patent No. 5.546,141, the Licensee the exclusive license to make, use and sell the patented Inventions through all channels of distribution and to otherwise practice the patent on an exclusive basis to the exclusion of the entire world including the inventor.
License Property
Sunglasses are provided wherein each lens opening has a fixed polarized lens and a rotatable polarized lens. A slide is carried by the frame, with each rotatable lens being connected thereto at locations outside of the lens openings. Lateral movement of the slide effects the rotation of the rotatable lenses, thereby varying the transitivity of the sunglasses.
Field of Use
The Patent licensed hereunder relates to an adjustable glasses product including but not limited to sunglasses, ski goggles and diving masks.

IPSCIO Record ID: 4911

License Grant
Licensor grants to Licensee an exclusive, worldwide, license, with the right to grant sublicenses, under Licensor Patents and Know-how to make, have made, use, import, offer for sale and sell the Catarex Products in the Licensee Field.
License Property
Licensor has developed a proprietary surgical instrument system designed to improve the removal of human cataracts, which instrument is generally referred to as Catarex-TM.

Catarex removes the lens nucleus and cortex in a single step through a small incision in the eye while leaving the lens capsule functionally intact.

Field of Use
Licensee Field means all applications of Catarex Products for human ophthalmic surgery.

IPSCIO Record ID: 2289

License Grant
We entered into an agreement whereby we acquired the patents, trademarks and technologies related to the X-Chrom contact Lens from Licensors, two individuals.
License Property
X-Chrom introduced the first commercially available contact lenses for colorblindness.

IPSCIO Record ID: 26035

License Grant
The Licensor agreed to provide development services toward the design of an ophthalmic implant to the Licensee.
License Property
The Licensee will continue to develop the ophthalmic implant that would provide continuous intraocular pressure monitoring.
Field of Use
The Licensee is an Optical Goods Manufacturer.

IPSCIO Record ID: 28313

License Grant
The Patent Owners hereby grant a world-wide, non-exclusive licence, to make, have made, use and sell Lenses under the Licensed Patents.
License Property
United Kingdom Patent No. GB 2,226,977

COUNTRY   APPLICATION NO.     PATENT NO.      STATUS
Australia          629280     Granted Patent
Great Britain          2,226,977 A    Lapsed, replaced by European (UK) 383425
Singapore          1137/93    Registered European (UK) Patent
Europe             383,425    Granted Patent Austria, Belgium,
                  Switzerland, Liechtenstein, Germany,
                  Denmark, Spain, France, Greece, Italy,
                  Luxembourg, Netherlands, Sweden and Great
                  Britain
Taiwan             39682      Granted Patent
USA            5,087,015  Granted Patent
Canada       2,007,536        Pending, under examination
Japan        3697/90          Pending, under examination
S. Korea     90355        Pending, under examination

Field of Use
This agreement relates to the manufacture of contact lenses by cast molding technology, and in particular to disposable plastics material molds for casting contact lenses.

IPSCIO Record ID: 372529

License Grant
Licensor of Switzerland grants to an irrevocable, worldwide, nonexclusive license, with no right to sublicense, under the Licensor Patent Rights to make, have made, import, export, use, sell, and offer to sell Licensee Licensed Products.
License Property
Licensors lotrafilcon A material represent the first successful silicone hydrogel Contact Lenses suitable for extended wear.

Biomedics Toric shall mean the cast molded Contact Lens for treating astigmatism currently marketed by Licensee under the trade name Biomedrcs® Toric comprising forty-five (45) percent ocufilcon D and fifty-five (55) percent water.

Licensor Licensed Products shall mean all Contact Lenses, including, but not limited to, O2Optix/AIROptix spherical and toric Contact Lenses. Contact Lens molds, and tools for making Contact Lens molds.

Field of Use
The field of use is contact lenses.

IPSCIO Record ID: 3730

License Grant
Licensor hereby grants to Licensee  an exclusive license under any and all of Licensor's right, title and interest in and to the Licensed Patents (i) to make, have made, use, sell, have sold, import and have imported Licensed Products, and (ii) to otherwise exploit the Licensed Patents and the subject matter of the Inventions; and to have any of the foregoing performed on its behalf by a third party for all applications.
The Licensee may grant and authorize subLicenses to SubLicensees within the scope of the License granted.
License Property
Licensor, owns, or has an ownership interest in (I) the AT-45A and/or the crystaiens (Illegible) intraocular lens.

Licensed Patents (13533.4061) – Method for making an accommodating intraocular lens  (i) to make, have made, use, sell, have sold, import and have imported Licensed Products, and (ii) to otherwise exploit the Licensed Patents and the subject matter of the Inventions; and to have any of the foregoing performed on its behalf by a third party for all applications.

Field of Use
Field shall mean any and all applications.

IPSCIO Record ID: 26782

License Grant
The U.S. Licensor hereby grants to Swiss Licensee an exclusive license under the Patent Rights, Know How and Trademarks, to make, have made, use, and sell Products in the Territory.
License Property
'PRODUCTS' shall mean ophthalmic medical devices used in the treatment of presbyopia, hyperopia, ocular hypertension and glaucoma, the manufacture, use or sale of which, would, but for this Agreement, constitute or would result in an infringement of the Patent Rights in any country including, but not limited to, the products set forth in the attached SCHEDULE B and any enhancements or improvements thereto.

Licensor's primary products are the patented PresVIEW device and the related PresVIEW Incision System, the automated surgical instrument for the surgical treatment of Presbyopia, Ocular Hypertension and Primary Open Angle Glaucoma, or POA Glaucoma, in the human eye.

The PresVIEW device consists of four separate tiny plastic segments, each about the size of a grain of rice, made from polymethylacrylate, or PMMA. PMMA has been implanted in the eye for other types of surgical procedures (intraocular lenses, hard contact lenses) for over fifty years. The surgeon uses the PresVIEW Incision System to make four superficial incisions in the quadrants of the sclera (white of the eye). The PresVIEW device is inserted into the superficial tunnels, causing a lift in the sclera that in turn reduces the crowding of the underlying muscles.

The full royalty rate schedule has not been made public, the only publicly available rate is a know-how royalty rate for countries where a relevant patent has expired.

Field of Use
The rights granted apply to the human eye.

IPSCIO Record ID: 2327

License Grant
We entered into an exclusive worldwide License Agreement with licensee for our patented soft multifocal contact lens designs.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.